Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Quizzes

psoriasis generalized pustular
Quiz
Feature Trivia: Optimizing Patient Care
11/29/2022
What score should patients with psoriasis have on the Psoriasis Epidemiology Screening Test to qualify for further investigation?
What score should patients with psoriasis have on the Psoriasis Epidemiology Screening Test to qualify for further investigation?
What score should patients with...
11/29/2022
The Dermatologist

Advertisement

atopic dermatitis
Quiz
Trivia: Gaps in Treatment Access
11/09/2022
11/09/2022
The Dermatologist
psoriatic arthritis on hand
Quiz
Trivia: Treatment Improves Health-Related Quality of Life in Patients With Psoriatic Arthritis
08/03/2022
Which treatment improved health-related quality of life, fatigue, pain, and work productivity in adults with active psoriatic arthritis?
Which treatment improved health-related quality of life, fatigue, pain, and work productivity in adults with active psoriatic arthritis?
Which treatment improved...
08/03/2022
The Dermatologist
severe hidradenitis suppurativa
Quiz
Trivia: Hidradenitis Suppurativa Risk Factor for Infection Following Procedures
07/26/2022
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following procedures have a heightened risk of infection in hidradenitis suppurativa skin lesions? Take the quiz!
Which of the following...
07/26/2022
The Dermatologist

Advertisement

atopic dermatitis on knee
Quiz
Trivia: Mental Health in Atopic Dermatitis
07/20/2022
07/20/2022
The Dermatologist
Dr Farberg on Tildrakizumab
Quiz
Trivia: Tildrakizumab's Durability and Safety
06/21/2022
True or False: There are more adverse events and serious adverse events occurred with tildrakizumab than with placebo.
True or False: There are more adverse events and serious adverse events occurred with tildrakizumab than with placebo.
True or False: There are more...
06/21/2022
The Dermatologist
atopic dermatitis (AD) Rash
Quiz
Trivia: Emollients Prioritization by Parents and Children with AD
06/20/2022
According to a study published in the British Journal of General Practice, children with eczema and their parents evaluate emollients based on different aspects. What is the emollient that is suitable for everyone?
According to a study published in the British Journal of General Practice, children with eczema and their parents evaluate emollients based on different aspects. What is the emollient that is suitable for everyone?
According to a study published...
06/20/2022
The Dermatologist

Advertisement

skin of color skin examination
Quiz
Trivia: Skin Cancer in Patients With Skin of Color
06/16/2022
Are patients with skin of color excluded from getting skin cancer?
Are patients with skin of color excluded from getting skin cancer?
Are patients with skin of color...
06/16/2022
The Dermatologist
psoriasis on hand and stomach
Quiz
Trivia: Risankizumab Comparable Safety and Efficacy Profiles in Psoriasis
06/15/2022
Risankizumab’s efficacy and safety profile is faster than another anti-IL23 when treating which of these options?
Risankizumab’s efficacy and safety profile is faster than another anti-IL23 when treating which of these options?
Risankizumab’s efficacy and...
06/15/2022
The Dermatologist
psoriasis
Quiz
Trivia: Tildrakizumab Approved for Adults With Moderate to Severe Plaque Psoriasis
06/09/2022
True or False: Currently, tildrakizumab is an IL-23 inhibitor approved for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
True or False: Currently, tildrakizumab is an IL-23 inhibitor approved for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
True or False: Currently,...
06/09/2022
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

August 2024
Volume 32
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Positive Phase III Data for Advanced Melanoma Treatment
10/20/2014
Positive results from CheckMate-037, a Phase III, randomized, controlled, open-label study of nivolumab (Opdivo, Bristol-Myers Squibb), versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously...
Positive results from CheckMate-037, a Phase III, randomized, controlled, open-label study of nivolumab (Opdivo, Bristol-Myers Squibb), versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously...
Positive results from...
10/20/2014
The Dermatologist
Chief Medical Editor Message
Navigating the Turbulent Health Care System
04/18/2017
Steve R. Feldman, MD, PhD
Our system of third-party payment has, for many years, struck me as fundamentally flawed.
Our system of third-party payment has, for many years, struck me as fundamentally flawed.
Our system of third-party...
04/18/2017
The Dermatologist
The Relevance of Vehicle in Low-Potency Topical Steroids: 2 Case Studies of Pruritic Condition
07/25/2014
07/25/2014
The Dermatologist
News
Psoriasis Treatment Improves Skin Clearance in Biologic Naïve Patients
03/14/2017
Patients with moderate plaque psoriasis, who were naïve to systemic biologic therapy, showed significantly improved skin clearance when treated with the oral, selective inhibitor of phosphodiesterase 4 apremilast (Otezla; Celgene Corp),...
Patients with moderate plaque psoriasis, who were naïve to systemic biologic therapy, showed significantly improved skin clearance when treated with the oral, selective inhibitor of phosphodiesterase 4 apremilast (Otezla; Celgene Corp),...
Patients with moderate plaque...
03/14/2017
The Dermatologist
New Topical Onychomycosis Treatment Approved
06/13/2014
Efinaconazole 10% topical solution (Jublia, Valeant Pharmaceuticals North America LLC, received approval as the first topical triazole approved for the treatment of onychomycosis of the toenails. The licensor and business partner for...
Efinaconazole 10% topical solution (Jublia, Valeant Pharmaceuticals North America LLC, received approval as the first topical triazole approved for the treatment of onychomycosis of the toenails. The licensor and business partner for...
Efinaconazole 10% topical...
06/13/2014
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
Riya Gandhi, MA, Associate Editor
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA, Associate Editor
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
Riya Gandhi, MA, Associate Editor
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
Riya Gandhi, MA, Associate Editor
02/28/2024
The Dermatologist
AD
Quiz
Trivia: Itch Cycle and OTC Products
12/27/2023
12/27/2023
The Dermatologist
psoriasis
Quiz
Trivia: Recommended Treatment For Psoriasis
12/20/2023
Jessica Garlewicz, Digital Managing Editor
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate...
12/20/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
Dupilumab Mechanism of Action
11/07/2023
Jessica Garlewicz, Digital Managing Editor
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use